Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason C Gallagher

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2022
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2022
Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US HospitalsCourtney L Luterbach, Liang Chen, Lauren Komarow, et al.
Open Forum Infectious Diseases|November 30, 2018
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter StudyJason C Gallagher, Michael J Satlin, Abdulrahman Elabor, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2022
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2022
Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US HospitalsCourtney L Luterbach, Liang Chen, Lauren Komarow, et al.
Open Forum Infectious Diseases|November 30, 2018
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infections: A Multicenter StudyJason C Gallagher, Michael J Satlin, Abdulrahman Elabor, et al.
The Lancet. Infectious Diseases|December 19, 2024
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational studyRyan K Shields, Lilian M Abbo, Renee Ackley, et al.
Pageof 7